E-mail: oncology2017@scientificfuture.com | USA : +1-646-828-7579, UK : +44-203-695-1242 | April 05-07, 2017, Barcelona, Spain  


Animesh Dhar

University of Kansas Medical Centre, USA

Dr. Dhar completed his PhD from University of Calcutta in Physiology and did his post-doctoral training in University of Puerto Rico in Biochemistry and University of Missouri-Columbia in Pharmacology. Then, Dr. Dhar became Research Track Assistant Professor in Pharmacology, University of Missouri-Columbia and then moved to University of Missouri-Kansas City School of Medicine as Associate Professor. He joined in the Department of Cancer Biology as an Associate Professor in University of Kansas Medical Center. Dr. Dhar has published more than 60 publications in the journals of international repute and about more than 10 reviews in the area of his research.

Srdjan Denic

United Arab Emirates University, UAE

Srdjan Denic is a Professor of Medicine in the College of Medicine and Health Sciences, UAE University, Al Ain, UAE. He has completed oncology training in Mount Sinai Hospital, NY, and has worked in the University Hospital, SUNY, Syracuse, NY. His current research focus is on human consanguinity and its effect on common blood disorders and risk of malignancy.

Miguel Hernandez Bronchud

Hospital General of Granollers, Barcelona, Spain

Miguel H. Bronchud was born in Barcelona but went to school in Italy (Liceo Massimo d'Azeglio, Turin) and to university in England: BA, MA in Natural Sciences (Biochemistry Part II) at the University of Cambridge and BM BCh at the University of Oxford. Following his MRCP (London 1986) he obtained a DM at Oxford and PhD Madrid. He has been a pioneer on Rhu-G-CSF (Filgrastim) and stem cells (CD34+) as well as cancer cells immune escape mechanisms related to mammalian placental feto-maternal gene expression programs

Yvonne TAY

University of Singapore(NUS), Singapore

Yvonne began her research career in Bing Lim's lab at the Genome Institute of Singapore, supported by an A*STAR Graduate Scholarship, and her PhD work led to key insights into the scope and mechanisms of microRNA activity (Miranda et al, Cell 2006; Tay et al, Nature 2008).Subsequently, she pursued her postdoctoral training in Pier Paolo Pandolfi's lab at Harvard Medical School and Beth Israel Deaconess Medical Center under a Special Fellow award from the Leukemia & Lymphoma Society, and this research led to the discovery that protein-coding transcripts can co-regulate the tumor suppressor PTEN by competing for shared microRNAs (Tay et al, Cell 2011; Karreth et al, Cell 2011). Yvonne has recently returned to Singapore to begin her independent research career, and has been awarded the Singapore National Research Foundation Fellowship and NUS President's Assistant Professorship to continue her research into this previously uncharacterized layer of gene regulation.

Ashrafi Hossein

Kingston Université, England

Ashrafi Hossein obtained his PhD in Cancer Biology from Beatson Institute for Cancer Research, Glasgow University in 1998. In the same year, he was offered a fellowship in the Medical Oncology, he was awarded a Royal Society Developing World Study Visit fellowship for distinguished research work. He joined Kingston University London in 2009 where he is an Associate Professor, course leader for cancer biology and teach on a range of modules, supervise PhD students, act as editorial board member of journals, and lead an active research group on the role of HPV and cancers and therapeutic approaches toward HPV related cancer.

Jin Rong Zhou

Harvard Medical School, Boston, USA

Jin-Rong (Joseph) Zhou is currently Associate Professor of Surgery at Harvard Medical School and the Director of the Nutrition/Metabolism Laboratory at the Beth Israel Deaconess Medical Center in Boston. He is also a member of the Nutrition curriculum Committee in Division of Nutrition at Harvard Medical School and a member of the Dana-Farber/Harvard Cancer Center. Dr. Zhou earned his PhD in Nutritional Sciences in 1994 from the University of Illinois at Urbana-Champaign, studied Bio-nutrition and Cancer as a postdoctoral student at Harvard from 1994-1996, and won the NIH National Individual Research Service Award from 1996-1999. He has served on over 30 study sections and special emphasis panels for the NIH, and several review panels for other national and international organizations including USDA, Susan G. Komen Breast Cancer Research Foundation, Italian Association for Cancer Research, Israel Science Foundation, Singapore National Medical Research Council, Research Fund Council of Hong Kong, and the National Science Foundation of China. Dr. Zhou's research priority is to investigate the complex issues dealing with nutrition and health. The long-term goal of his research is to identify nutritional and bioactive components for the prevention and treatment of chronic diseases, such as cancer and metabolic disorders. Dr. Zhou is the recipient of over 30 research grants from the NIH, Department of Defense, and several other funding organizations, and has published about 60 peer-reviewed original research papers, review papers and book chapters/editorials. Dr. Zhou has served the peer reviewer for over 70 scientific journals, the Guest Editor for American Journal of Clinical Nutrition, the Managing Editor for Frontiers in Biosciences, the Field Editor for the journal Functional Foods in Health and Disease, the Editors-in-Chief for Nutrition and Metabolic Insights and the Journal of Health Sciences, and the Editorial Board for several scientific journals

Anand kumar Singh

Harvard Medical School, Boston, USA

Biography will be updated soon...

Yunfeng Zhou

Zhongnan Hospital, Wuhan University, China

Yunfeng Zhou is a professor of Radiation Oncology, and he was the Dean of Medical School and the President of Zhongnan Hospital,Wuhan University.From 1986 to 1991,He studied for his Oncology Diploma(DIS) in Lyon,France. He has been working at the Department of Radiation Oncology and Medical Oncology as a director of Hubei Cancer Clinical Study Center , Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Radiotherapeutic Quality Control Center. His main research fields including radiation biology which focuses on the radiosensitivity modified by telomere/telomerase and radiation-guided gene therapy of cancer. Prof. Zhou has published more than 100 papers in international and national journals. Due to his outstanding contributions for Sino-France medical education exchange,the French government awarded him French knight badge(2006) and National Order of the Legion of Honour(2009).

Hatim Husain

University of California, United States

Biography will be updated soon...

Michael Gibson

UH Seidman Cancer Center, United States

Biography will be updated soon...

Yuval Tabach

The Hebrew University, United States

Biography will be updated soon...

Daniel Melling

University of Dundee, UK

Biography will be updated soon...

Oncology-2017 | by: Scientific Future Group